Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Summary
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer(HARMONi-GI3)
Official title: A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2025-11-18
Completion Date
2029-11-30
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Interventions
Drug: Ivonescimab Injection
Subjects will receive Ivonescimab Plus mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) via intravenous infusion (IV) Q2W, up to 8 cycles. Afterward, Ivonescimab plus Leucovorin and 5-Fluorouracil will be used for maintenance treatment (administered on Day 1 of each cycle, Q2W) for up to 2 years.
Drug: Bevacizumab Injection
Subjects will receive bevacizumab Plus mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) via intravenous infusion (IV) Q2W, up to 8 cycles in treatment periods per the randomization schedule. Afterward, bevacizumab Plus 5-FU and Leucovorin will be used for maintenance treatment (administered on Day 1 of each cycle, Q2W) up to 2 years.
Locations (54)
Clinical Study Site
Goodyear, Arizona, United States
Clinical Study Site
Beverly Hills, California, United States
Clinical Study Site
Cerritos, California, United States
Clinical Study Site
Corona, California, United States
Clinical Study Site
Duarte, California, United States
Clinical Study Site
Huntington Beach, California, United States
Clinical Study Site
Irvine, California, United States
Clinical Study Site
Irvine, California, United States
Clinical Study Site
Los Angeles, California, United States
Clinical Study Site
Los Angeles, California, United States
Clinical Study Site
Murrieta, California, United States
Clinical Study Site
Orange, California, United States
Clinical Study Site
Pasadena, California, United States
Clinical Study Site
Torrance, California, United States
Clinical Study Site
Upland, California, United States
Clinical Study Site
West Hollywood, California, United States
Clinical Study Site
New Haven, Connecticut, United States
Clinical Study Site
Norwich, Connecticut, United States
Clinical Study Site
Hialeah, Florida, United States
Clinical Study Site
Orlando, Florida, United States
Clinical Study Site
Port Saint Lucie, Florida, United States
Clinical Study Site
Newnan, Georgia, United States
Clinical Study Site
Chicago, Illinois, United States
Clinical Study Site
Elmhurst, Illinois, United States
Clinical Study Site
O'Fallon, Illinois, United States
Clinical Study Site
Fort Wayne, Indiana, United States
Clinical Study Site
Edgewood, Kentucky, United States
Clinical Study Site
Saint Louis Park, Minnesota, United States
Clinical Study Site
Billings, Montana, United States
Clinical Study Site
Lincoln, Nebraska, United States
Clinical Study Site
New Brunswick, New Jersey, United States
Clinical Study Site
Mineola, New York, United States
Clinical Study Site
New York, New York, United States
Clinical Study Site
The Bronx, New York, United States
Clinical Study Site
Cincinnati, Ohio, United States
Clinical Study Site
Philadelphia, Pennsylvania, United States
Clinical Study Site
Philadelphia, Pennsylvania, United States
Clinical Study Site
Hermitage, Tennessee, United States
Clinical Study Site
Fort Worth, Texas, United States
Clinical Study Site
Salt Lake City, Utah, United States
Clinical Study Site
Charlottesville, Virginia, United States
Clinical Study Site
Spokane, Washington, United States
Clinical Study Site
Tacoma, Washington, United States
Clinical Study Site
Charleston, West Virginia, United States
Clinical Study Site
Montreal, Quebec, Canada
Clinical Study Site
Aichi, Japan
Clinical Study Site
Chiba, Japan
Clinical Study Site
Fukuoka, Japan
Clinical Study Site
Gifu, Japan
Clinical Study Site
Hokkaido, Japan
Clinical Study Site
Osaka, Japan
Clinical Study Site
Tokyo, Japan
Clinical Study Site
Rio Piedras, Puerto Rico
Clinical Study Site
London, England, United Kingdom